| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Pulmonary Sarcoidosis | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Sarcoidosis | |||||
| Sarcoidosis, Pulmonary | |||||
| 3 | More general conditions related to this trial | ||||
| Lung Diseases | |||||
| Lung Diseases, Interstitial | |||||
| Lymphatic Diseases | |||||
| Lymphoproliferative Disorders | |||||
| Respiratory Tract Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| Pentoxifylline | |||||
| 5 | More general drug interventions related to this trial | ||||
| Antioxidants | |||||
| Cardiovascular Agents | |||||
| Enzyme Inhibitors | |||||
| Free Radical Scavengers | |||||
| Hematologic Agents | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Phosphodiesterase Inhibitors | |||||
| Physiological Effects of Drugs | |||||
| Platelet Aggregation Inhibitors | |||||
| Protective Agents | |||||
| Radiation-Protective Agents | |||||
| Therapeutic Uses | |||||
| Vasodilator Agents | |||||
| 6 | Sponsors listed in this trial | ||||
| National Heart, Lung, and Blood Institute (NHLBI) | |||||
|
